I. Introduction
The physiological basis of cell excitability is the volt age-dependent and ion-selective permeability of the cell membrane. Experimental evidence indicates that the two properties do not apply to the entire membrane surface, but are restricted to specific sites known as channels. These are proteic structures spanning the entire lipid bilayer and randomly distributed within it. Ion channels are specialized integral membrane proteins that undergo conformational changes to allow transmembrane move ment of ions. The increases in membrane permeability to Na+, K+ and Ca2+ are mediated by voltage-dependent Na+, K+ and Ca2+ channels, respectively. Neurotoxins that selectively block the voltage-sensitive Na+, K+ or Ca2+ channels are essential tools for understanding the molecular basis of electrical excitability. From this view point, a variety of natural toxins have been extensively studied by pharmacologists, physiologists and bio chemists because they interact with specific channels on excitable membranes (1) .
Ca2+ is critically involved in numerous cellular regula tory processes including excitation-contraction coupling, excitation-secretion coupling, neuronal excitability, ionic membrane permeability and cell growth and differentia tion. In muscle biology, especially lacking is knowledge of the mechanism whereby the sarcoplasmic reticulum (SR) releases Ca2+ that has been accumulated during muscle relaxation (2) . In striated muscle contraction, Ca2+ activation of force development is triggered by Ca2+ binding to myofilaments, which causes a conforma tional change in the contractile machinery to stimulate the actin-myosin interaction. It is generally accepted that reversible protein phosphorylation plays an essential role in controlling a wide range of cellular events such as smooth muscle contraction, cell division, cell signaling, differentiation and metabolism (3) . Selective modulators (inhibitors and/or activators) are extremely useful probes for characterizing target proteins.
This review focuses on research that has given insight into the cellular and molecular mechanisms of action of natural products isolated from marine organisms, ter restrial plants and microorganisms. These studies have revealed the molecular regulatory mechanisms of ion channels, excitation-contraction coupling and protein phosphorylation through the use of these compounds as chemical probes. 
II. Elucidation of Molecular Properties of Ion Channels
II-1. Natural products that affect Na+-channel function
Voltage-dependent Na+ channels are found in virtually all multicellular animals, where they play a key role in the initiation of electrical activity. The Na+ channel from rat brain consists of a large a-subunit (260-kDa) that is asso ciated with smaller ~1 (36-kDa) and P2 (33-kDa) subunits. The p2-subunit is linked to the a-subunit by disulfide bonds. Na+-channel a-subunit cDNAs have been isolated from a variety of sources including rat brain, skeletal muscle and cardiac muscle. Each cDNA encodes a protein consisting of four homologous domains (I-IV), each consisting of six predicted transmembrane a-helices (S1-S6).
Characterization of neurotoxin receptor sites 1 to 5 Numerous neurotoxins that alter Na+-channel function bind at five separate receptor sites in the molecule (Table  1) (1). The heterocyclic guanidine derivatives, tetrodotox in (TTX) from puffer fish of the suborder Gymnodontes and saxitoxin from the dinofragellate Gonyaulax catanel la ( Fig. 1) , specifically inhibit the ion permeability of Na+ channels without affecting voltage-dependent K+ channels and Ca2+ channels. The isolation, structure determination and general pharmacology of the toxins have been reviewed in detail. Several lines of experimental evidence suggest that these positively charged toxins are bound close to the extracellular mouth of the channel in a region containing negatively charged groups (SS 1 SS2 region) (4 6). Recently, it has been shown that a single mutation in rat Na+ channel II that reduces net negative charge renders the channel insensitive to TTX and saxi toxin and resulted in a Na+ channel with a reduction in its single-channel conductance without preventing gating function. Ligand-binding experiments with [3H]TTX and
[3H]saxitoxin show that both toxins bind to a common receptor site (receptor site 1) associated with Na+ chan nels. These results suggest that receptor site 1 is located at the extracellular vestibule or inside the ion-conducting pore of the channel. Both toxins have been employed as selective ligands for purification and subsequent struc tural characterization or Na+-channel protein. The second receptor site (receptor site 2) binds the lipid-soluble toxins such as batrachotoxin (steroidal alkaloid from the Colombian frog Phyllobates aurotaenia), aconitine (aconitum alkaloid from the plant Aconitum napellus), veratridine (veratrum alkaloid from liliaceous plants of the species Veratreae) and grayanotoxin (terpene possess ing the andromedane skeleton from plants of the family Ericaceae). These toxins shift the voltage-dependence of activation to more negative membrane potentials and block Na+-channel inactivation, suggesting that this site may be located on a region of the Na+ channels im portant for both of these voltage-dependent processes. The third receptor site (receptor site 3) binds some poly peptides, a-scorpion toxins from the North African scor pion Leiurus quinquestratus and sea anemone toxin from the sea anemone Anemonia sulcata; the a-scorpion toxins bind to receptor site 3 on the extracellular surface of the membrane in a voltage-dependent manner to slow inacti vation of Na+ channels, suggesting that the binding site for these molecules represents an extracellular site that undergoes voltage-dependent conformational changes that are required for channel inactivation. Photolabeling of the brain Na+ channel with a photoreactive scorpion toxin derivative resulted in labeling of the a and 81 subunits. However, actions of a-scorpion toxins are nor mal on channels resulting from expression of the a-sub unit alone, indicating that the physiologically relevant sites are on that subunit. The sites on the a-subunit that were photolabeled were identified by proteolytic digestion of the labeled protein followed by identification of the labeled fragment with site-directed antibodies. This site is located on the extracellular loop connecting transmem brane segments S5 and S6. A new class of scorpion toxins (r3-scorpion toxins) isolated from the American scorpion Cenlruroides sculpturatus binds at receptor site 4 in Na+ channels. These toxins modify Na+-channel activation rather than the inactivation process. ~-Scorpion toxin binding is not voltage-dependent in contrast to a-scor pion toxin binding.
The oxygenated polyether compounds such as breve toxin and ciguatoxin (CTX) (7) isolated from marine dinoflagellates (Fig. 2) bind at a new common receptor site (receptor site 5) associated with Na+ channels to cause repetitive firing and an increase in the frequency of action potentials.
CTX causes a type of food poisoning known as ciguatera and is produced by the benthic dinoflagellate Gambierdiscus toxicus and transmitted to a variety of reef fish through the food chain. CTX has been reported to cause depolarization of the plasma membrane (8) and contraction of the vas deferens (9, 10) . It also has a con centration-dependent inotropic action on the papillary muscles (11) and left atria (11, 12) , and these effects of CTX are abolished by TTX. These pharmacological stud ies have clearly indicated that the inotropic response to lower concentrations of CTX is primarily the result of an indirect action mediated through noradrenaline release, whereas that induced by higher concentrations occurs mainly through a direct action on cardiac muscle. Further more, our detailed electrophysiological studies have re vealed that in cardiac myocytes, CTX shifts the voltage dependence of Na+-channel activation toward more hyperpolarized potentials without affecting the time course of inactivation or the peak current amplitude (12) . The chemical structure of dinoflagellate toxins that bind to receptor site 5 associated with Na+ channels.
Characterization of Na+ channel by a novel type of marine toxins Cone shells have a well-developed venom apparatus to catch their prey, such as fishes, shells and worms (13) . Conus geographus is highly toxic and has been respon sible for human injury. The crude venom of C. geographus has an inhibitory effect on the contractile response of stimulated skeletal muscle (14, 15) . Geographutoxins I and II (GTX I and II) composed of 22 amino acid residues have been isolated from the venom by monitor ing the pharmacological activity (16) and are classified as p-conotoxin GIIIA and GIIIB, respectively. The primary structures of the two peptides are very similar to each other (see Fig. 1 ) (17) .
GTX II was shown to inhibit twitch responses of the isolated mouse diaphragm to direct stimulation, and the IC50 value of GTX II is a little higher than that of TTX. The toxin blocks the action potential of the guinea pig skeletal muscle without affecting the resting membrane potential (18). Voltage clamp experiments on bullfrog skeletal muscle fiber have indicated that Na+ currents are abolished by GTX II. However, action potentials of the crayfish giant axon, mouse neuroblastoma NIE-115 cell and guinea pig cardiac muscle are not affected by GTX II even at high concentrations (19). These findings have indicated that GTX II selectively blocks skeletal muscle Na+ channels in much the same way as TTX. GTX II has been shown to distinguish two different types of voltage sensitive Na+ currents: GTX II-sensitive and GTX II-in sensitive currents, which correspond respectively to cur rents with high or low TTX sensitivity (20, 21). In addi tion, GTX II at higher concentrations causes blockade of neuromuscular transmission in skeletal and smooth mus cle preparations (22, 23) .
GTX II has been demonstrated to inhibit [3H]saxitoxin binding to Na+ channels in skeletal muscle homogenates and T-tubular membranes at concentrations similar to those that block muscle contraction. The Kd value is in creased by GTX II, while the Bmax value is not modified, indicating a competitive mode of inhibition (24, 25). However, [3H]saxitoxin binding to membranes of the su perior cervical ganglion is not modified by GTX II even at high concentrations. These results suggest that GTX II interacts competitively with saxitoxin in binding at neuro toxin receptor site 1 associated with the Na+ channel in a highly tissue-specific manner. GTX II is the first reagent that discriminates at this site between nerve and muscle Na+ channels. GTX II is used to identify these tissue specific regions of the Na+-channel structure at neuro toxin receptor site 1. It has become a useful chemical probe for classifying Na+-channel subtypes.
Various analogues of GTX II have been synthesized to elucidate the molecular nature of its active center for blocking skeletal Na+ channels. Analysis of NMR or CD spectral data of these analogues, including GTX II, indicates the similarity of their conformations (26). The arginine residue at the 13th position and basicity of the molecule are important for the inhibitory activity. The structure-activity relationship studies lead to the conclu sion that arginine is a key residue for peptide toxins to interact with receptor site 1 in Na+ channels.
Striatoxin (StTX), a glycoprotein (molecular weight of 25,000), has been isolated from Conus striatus, a piscivo rous Conidae, as a cardiotonic component (27). StTX causes an inotropic effect on isolated guinea pig left atria (28) and a rhythmic contraction of the ileum followed by relaxation (29). StTX provoked action potentials with a plateau phase of long duration. These effects of StTX are reversed by TTX. Whole cell patch-clamp experiments have showed that StTX slows Na+-channel inactivation without affecting the time course of channel activation (30). The binding of saxitoxin or a-scorpion toxin to nerve Na+ channels is not significantly affected by StTX. A possible explanation of these results has been that StTX binds to a new receptor site associated with Na+ chan nels, at which specific effects on channel inactivation can occur. These observations suggest that the inotropic effect of StTX is caused by increasing Na+ permeability of Na+ channels due to slowed inactivation of channel kinetics and that this may result in an increase in Ca' availability in cardiac muscle cells. Mast cell-degranulating (MCD) peptide, a disulfide rich basic peptide has been purified from bee venom. It is composed of 22 amino acid residues and contains two disulfide bridges (Fig. 3) Interestingly, an endogenous peptide equivalent of MCD peptide has been found in brain extracts using binding experiments and radioimmunoassay techniques. An at tractive interpretation is that a MCD-like peptide plays an important role in long-term potentiation.
A novel peptidyl inhibitor of voltage-dependent K+ channels named margatoxin (MgTX) has been isolated from the venom of the new world scorpion Centruroides margaritaus and the primary structure of the 39 amino acid peptide named margatoxin has been determined by amino acid compositional analysis and peptide sequenc ing (Fig. 3) . MgTX potently inhibits binding of radio labeled charybdotoxin (ChTX) to voltage-dependent K+ channels in brain synaptic plasma membranes (37). Like ChTX, MgTX blocks the N-type current of human T lymphocytes (Kvl.3 channel). MgTX is 20-fold more po tent than ChTX in K+-channel blocking activity (EC50 =50 pM) . Recombinant MgTX has been expressed in Es cherichea coli as part of a fusion protein. After cleavage and folding, purified recombinant MgTX has been shown to display the same properties as native peptide. Replace ment of the COOH-terminal histidine residue of MgTX with asparagine reduces its potency by tenfold, suggesting that the COOH-terminal amino acid may play an im portant role in the binding of MgTX to the channels. MgTX displays significant sequence homology with previously identified K+-channel inhibitors (e.g., ChTX, iberiotoxin, noxiustoxin). MgTX has become a useful tool for investigating the physiological role of Kvl.3 channels because of its potency and unique selectivity. ChTX is a 37 amino acid basic peptide purified from the venom of the scorpion Leiurus quinquesttiatus var. hebraeus ( Fig. 3 ) (38). It was first reported to be a potent blocker of the Cat+-activated K+ channels (38). Sub sequently, ChTX has been shown to block other types of K+ channels (39, 40). ChTX seems to bind to the outer face of the channel to block K+ permeability through an electrostatic mechanism whereby positive charges on the toxin molecule interact with negatively charged residues located within or near the ion-transporting pore of the channel (41). This electrostatic mechanism is also con sidered to be involved in the interaction of ChTX with voltage-dependent K+ channels in human T-lymphocytes. Scatchard analysis of An interesting finding is that three different rat brain cDNA clones that express voltage-dependent K+ channels in Xenopus oocytes are sensitive to ChTX (39, 42), although the molecular properties of the rat brain ChTX receptor are yet to be revealed.
Characterization of Ca"-activated K+ channels by pep tide toxins
Small-conductance Cat+-activated K+ channels are defined as those having single-channel conductances of less than 20 pS. These channels are widely distributed in both excitable and nonexcitable cells. Apamin has been isolated as a minor component of the venom of the honeybee Apis mellifera. It is an 18 amino acid polypep tide neurotoxin (molecular weight of 2000) containing two disulfide linkages (Fig. 3) . Apamin is the first K+ channel toxin to be isolated and characterized. Apamin sensitive Cat+-activated K+ channels are known to under lie neurotransmitter and hormone-induced increase in K+ permeability in a variety of cells. It has been demon strated that the ionic currents through these channels are responsible for maintaining the slow after-hyperpolar izing potential that follows bursts of action potentials. It has been used as a pharmacological tool to characterize ionic currents flowing through K+ channels.
[125I]Apamin has been used to characterize specific high affinity binding sites for this toxin in brain synaptosomes (43), embryonic neurons (44) and hepatocytes (45). Apamin binding has been correlated with the inhibition of a specific class of Cat+-activated K+ channels in certain neurons.
Leiurotoxin I, an inhibitor of apamin binding, has been purified to homogeneity in three chromatographic steps from the venom of the scorpion Leiurus quinques triatus hebraeus (Fig. 3 ). It is a 3.4-kDa peptide with little structural homology to apamin, although it has some homology to other scorpion toxins such as ChTX and noxiustoxin. Both the toxins cause a contraction of taenia coli previously relaxed with epinephrine, and they block the after-hyperpolarization due to Cat+-activated K+ channel activity in cultured muscle cells. Like apamin, leiurotoxin I blocks the epinephrine-induced relaxation of guinea pig teniae coli (ED50=6.5 nM) without affecting the rate or force of contraction in guinea pig atria or rabbit portal vein preparation. Thus, leiurotoxin I and apamin demonstrate similar pharmacological properties in a variety of tissues in spite of structurally unrelated peptides (46). Both the toxins appear to be useful tools for elucidating the physiological role of the small con ductance, Cat+-activated K+ channels in different tissues.
Leiurotoxin I completely inhibits [125I]apamin binding to rat synaptosomal membranes with a K; of 75 jiM, in dicating that it is 10-20-fold less potent than apamin. Leiurotoxin I is not a strictly competitive inhibitor of this binding. The total synthesis of this scorpion neurotoxin as well as some aspects of its structure-function relation ships have been studied. Iberiotoxin (IbTX), a peptide inhibitor of the high con ductance Ca2+-activated K+ channel, has been purified to homogeneity from the venom of the scorpion Buthus tamulus (48) (Fig. 3) . IbTX consists of a single 4.3-kDa polypeptide chain and its complete amino acid sequence has been determined. It has been demonstrated that IbTX reversibly blocks Ca2+-activated K+ channels in excised membrane patches from bovine aortic smooth muscle and interacts at the outer face of the channel (48) . Its blockage of channel activity appears distinct from that of ChTX since IbTX decreases both the probability of channel opening and the channel mean open time. It is noticeable that IbTX is a selective inhibitor of high conductance Ca2+-activated K+ channels without affecting other types of voltage-dependent ion channels including other types of K+ channels that are sensitive to ChTX. Furthermore, it has been demonstrated that IbTX is a partial inhibitor of [1251]ChTX binding in bovine aortic sarcolemmal membrane vesicles (K;=250 pM). The Scatchard analysis suggests that IbTX functions as a noncompetitive inhibi tor of ChTX binding. These data suggest that IbTX intrer acts at a distinct site on the channel and modulates ChTX binding by an allosteric mechanism. Therefore, IbTX defines a new class of peptidyl inhibitor of Ca2+ activated K+ channels.
An important finding is that like ChTX, IbTX is only able to block the skeletal muscle membrane Ca 2+-acti vated K+ channels incorporated into neutral planar bi layers when applied to the external side (49) . From single channel recording, it is possible to determine that IbTX binds to the Ca 2+ -activated K+ channel in a bimolecular reaction. A detailed electrophysiological analysis gives an apparent equilibrium dissociation constant of 1.16 nM. This constant is tenfold lower than that of ChTX. Tetraethylammonium competitively inhibits the IbTX binding to the channel, suggesting that this toxin binds to the channel external vestibule. Increasing the external K+ concentration decreases the association rate constant without affecting the dissociation reaction. This indicates that the surface charges located in the external mouth of the channel play an important role in modulating toxin binding.
Kaliotoxin (KTX), a peptidyl inhibitor of the high con ductance Ca2+-activated K+ channels, has been isolated from the venom of the scorpion Androctonus mauretani cus mauretanicus and has been shown to be a single 4 kDa polypeptide chain (Fig. 3) . Electrophysiological ex periments have revealed that KTX specifically inhibits the whole cell Ca 2+-activated K+ current in nerve cells (50) . KTX has no effect on voltage gated K+ currents (delayed rectifier and fast transient A current) or on L-type Ca2+ currents. KTX interacts in a one-to-one way with Ca2+ activated K+ channels with a Kd of 20 nM. In single channel experiments on high conductance Ca2+-activated K+ channels, KTX acts at the outer face of the channel to cause a transient period of fast-flicker block followed by a persistent channel blockade. The blocking action of KTX is not voltage-dependent, suggesting differences in the blockade of Ca2+-activated K+ channels by KTX and ChTX. An interesting observation is that comparison of KTX and ChTX sequences leads to the identification of a short amino acid sequence that may be implicated in the toxin-channel interaction. Therefore, KTX should be useful for elucidating the molecular mechanism of the high conductance Ca2+-activated K+ channel.
Characterization of Ca2+-activated K+ channels by in dole alkaloids
Tremogenic indole alkaloids induced neurological dis orders including stagges syndromes in ruminants (51, 52) . Binding of [125I]ChTX to high conductance Ca 2+-acti vated K+ channels in the sarcolemmal membrane of aortic smooth muscle is inhibited by paspalitrem A, paspalitrem C, afltrem, penitrem A (Fig. 3) and paspalinine, but en hanced by three structurally related compounds, paxil line, verruculogen and paspalicine. On the basis of bind ing studies, it is probable that covalent incorporation of ChTX, all these compounds potently inhibited high conductance Ca2+-activated K+ channels with no effect on other types of K+ channels in electro physiological experiments. Taken together, these data suggest that the indole diterpenes are the most potent nonpeptidyl inhibitors of high conductance Ca 2+-acti vated K+ channels. It is also suggested that some of their pharmacological properties could be explained by inhibi tion of the channels, although tremorgenicity may be un related to channel block.
Application of openers of Ca 2 +-activated K+ channels
A large number of synthetic openers of Ca 2+-activated K+ channels have now been developed by pharmaceutical industries for the treatment of cardiovascular diseases. Recently dehydrosaponin-1 (DHS-1), a triterpenoed glyco side that was isolated from the medicinal herb Desmodi um adscendens, has been demonstrated to be an opener of Ca2+-activated K+ channels (Fig. 3) (53) . DHS-1 is effec tive only when it is applied intracellularly because of the poor membrane permeability of this compound. DHS-1 has been attracting much attention since it is the first compound that has been found to open K+ channels via an interaction with the 3-subunit of Ca 2+ -activated K' channels. Maxikdiol, another opener of Ca 2 '-activated K+ channels, has been isolated from a fermentation broth (Fig. 3) and identified by its ability to displace labeled ChTX from its binding site (54) .
[125I]ChTX binding to Ca2+-activated K+ channels in aortic sarcolema is in hibited by maxikdiol, where as that to voltage-dependent K+ channels in brain synaptic membranes is not affected by it even at high concentrations, indicating specificity. The biological data indicate that the pharmacological profile of maxikdiol is very similar to that of structurally dissimilar DHS-1. Both DHS-1 and maxikdiol should be essential tools for investigating the regulation of channel gating of Ca2+-activated K+ channels.
11-3. Natural products that affect Ca2+-channel function
There has been a dramatically growing awareness that Ca 2+ movements in the cell can play a central role in many cellular functions. From this point of view, sub stances that influence cellular Ca2+ movements provide valuable probes for the elucidation of various cellular functions. The plasma membrane separates extracellular mM Ca2+ from intracellular pM Ca 2+ concentrations. Ca2+ entry occur through Ca2+ channels. Six classes of voltage-dependent Ca2+ channels (termed L, N, P, T, R and Q) have been defined on the basis of their physiolog ical and pharmacological properties (55) . Molecular clon ing has also revealed the existence of six high-voltage dependent Ca 2+ channel subtypes. Expression studies have indicated that basic high-voltage-dependent channel function, which is characteristic of the L (skeletal muscle, cardiac muscle and neuroendocrine tissue)-, N-, P-, Q and R-type channels is carried by the corresponding al subunits (56) . Auxiliary subunits, such as a2/6 and ~3, modulate the kinetics of activation, inactivation, current density and drug binding, thereby creating considerable potential for multiple Ca2+ channel functions.
Characterization of L-type channels by calciseptine
The L-type Ca 2+ channel has been extensively studied by numerous pharmacologists. Blockers of this type of channel can abolish contractions in cardiac and smooth muscle cells. A high number of relatively simple organic molecules including 1,4-dihydropyridines, phenylallyla mines and benzothiazepines have been extensively studied because these drugs have been used clinically for their antianginal, vasodilator, and antiarrhythmic properties. Calciseptine has been isolated as a specific Ca2+-channel blocker from the venom of the black mamba Dendroaspis polylepis polylepis. It contains 60 amino acids and has been fully sequenced (Fig. 4) . Calciseptine causes a relax ation of smooth muscle and an inhibition of cardiac muscle. The pharmacological properties of the peptide has been shown to be similar to that of drugs such as the 1,4-dihydropyridines, which are important in the treat ment of cardiovascular diseases (57) . Calciseptine, like the 1,4-dihydropyridines, selectively blocks L-type Ca 2+ channels without altering the activity of N-type and T type channels (57) . It is the only natural polypeptide that has been shown to be a specific inhibitor of L-type Ca 2+ channels.
Characterization of N-type channels by w-conotoxin ((o CgTX)
It has been reported that the N-type Ca 2+ channel is present in neuronal cells and is blocked by a polypeptide toxin isolated from C. geographus, w-CgTX (Fig. 4) . The peptide toxins have been shown to block individual Ca 2+ channel subtypes. w-CgTX was initially reported to block both the N and L-type channels in nerve prepara tions (58) . Detailed electrophysiological experiments, how ever, have shown that the toxin selectively blocks N-type channels without affecting the L-type channels (59-61).
Voltage-dependent Ca2+ channels in the nervous tissues can be classified pharmacologically into three subclasses: w-CgTX-sensitive, dihydropyridine-sensitive, and both w-CgTX and dihydropyridine-insensitive.
Purification and elucidation of w-CgTX target proteins have been extensively studied by numerous investigators. Cross-linking experiments with labeled w-CgTX reveal that a 210-kDa (62) or 170-kDa (63) protein is a target molecule in synaptosomal membranes of chick brain. In rat brain, bands of 310, 240 and 34 kDa (64) or 220 and 33 kDa (63) are labeled. Recently, the w-CgTX receptor (N-type Ca2+ channel) of rabbit brain membranes has been purified by heparin chromatography, immunoaffin ity chromatography and density gradient centrifugation (65). The channel is composed of four subunits with molecular weights of 230 (a 1 B), 160 (a2o), 57 (r33) and 95 kDa (glycoprotein subunit). Reconstitution experiments with the purified w-CgTX receptor indicated that the complex forms functional Ca2+ release channels with the same pharmacological properties as those of native w CgTX-sensitive Ca 2+ channels. Recent biochemical stud ies suggest that the subunit composition of w-CgTX receptor is similar to, but distinct from, that of the dihydropyridine receptor (66). Furthermore, molecular biological studies have made it possible to express the complementary DNA encoding the human neuronal a1 subunit producing w-CgTX-sensitive current (67). Characterization of w-CgTX-insensitive Ca 2+ channels in neurons by a novel conus toxin Voltage-dependent Ca2+ channels that control neuro transmitter release are blocked by w-CgTX-GVIA from C. geographus, the most widely used inhibitor of neurotransmitter release. However, many mammalian synapses are w-CgTX-GVIA insensitive. w-CgTX-MVIIC from the cone shell C. mgus has been shown to inhibit w-CgTX-GVIA-resistant synaptic transmission, depolari zation-induced "Ca 2+ uptake in rat synaptosome prepa rations, "P" currents in cerebellar Purkinje cells and cur rents in CA1 hippocampal pyramidal cells (68). Further more a peptide toxin named w-agatoxin-IVA from funnel web spider venom is a potent inhibitor of both Ca 2+ entry into rat brain synaptosomes and P-type Ca2+ channels in rat Purkinje neurons (69). w-Agatoxin-IVA will facilitate characterization of brain Ca2+ channels resistant to exist ing channel blockers and may assist in the design of neuro protective drugs.
Characterization
of a novel type of Ca 21 -permeable channels by marine toxins Maitotoxin (MTX), the most potent marine toxin known, has been isolated from poisonous fish Ctenochaetus striatus and the dinoflagellate Gambierdis cus toxicus (Fig. 5) Recently, it has been reported that MTX increases for mation of inositol phosphates from phosphoinositides and arachidonic acid from phospholipids in a variety of cells (84) . However, MTX-induced phosphoinositide breakdown is not modified by Ca 2+ antagonists and is stimulated at lower concentrations of MTX than those required to elevate neurotransmitter release from PC12 cells. The inositol phosphate formation by MTX may be a secondary response to Ca2+ influx. The mechanism of action of MTX on phosphoinositide metabolism remains to be elucidated in detail.
Recently, we have purified zooxanthellatoxin-A (ZT A), a novel 62-metmbered lactone, from cultured zoox anthella (Symbiodinium sp.) isolated from the flatworm Amphiscolops sp. (Fig. 5) These results suggest that ZT-A increases Ca2+ influx into platelets, resulting in the secondary release of TXA2. It is also suggested that the response to ZT-A is associated with tyrosine phosphorylation of p42 mitogen-activated protein kinase.
III. Elucidation of Excitation-Contraction
Coupling of Muscle 111-1. Natural products that affect Ca 2+-release-channel function
Molecular properties of the ryanodine receptor
Muscle contracts when the free Ca2+ concentration of the myofibrillar space reaches 10-6 to 105 M by the release of Ca2+ from the SR via Ca2+-release channels. Evidence from recent studies has indicated that two classes of intracellular Ca2+-release channels, ryanodine receptors and inositol ( (92) . The sequence of 5037 amino acids composing the skeletal ryanodine receptor has been deduced by cloning and sequencing the complementary DNA (93) . The ryanodine receptor has recently been shown to be expressed not only in skeletal (RYR1) and cardiac (RYR2) muscle, but also in the cen tral nervous system (RYR3), and the cloning of RYR3 gene has revealed that this subtype is widely expressed in several tissues and cells (94) .
Characterization of Ca2+-release channels by eudistomin D analogues
Caffeine, a plant alkaloid from Thea sinensis L, has been used most extensively as a typical inducer of Ca2+ release from SR, but is not used as a chemical probe for molecular characterization of the caffeine binding site because of its low affinity. Recently, we have found that eudistomin D and related substances isolated from a marine tunicate Eudistoma olivaceum induce Ca2+ release from a heavy fraction of the fragmented SR (HSR) (95) . Structure-activity relationship studies to find deriva tives that are more potent and can be radiolabeled have lead to the discovery of 7-bromoeudistomin D (BED) and 9-methyl-7-bromoeudistomin D (MBED) (Fig. 7 , Table  2 ) (95-98). The rate of 45Ca2+ release from SR was in creased markedly by BED, MBED or caffeine. The 50% effective concentrations of BED, MBED and caffeine are approximately 2 pM, 1 pM and 1 mM, respectively, in dicating that BED and MBED are 500 and 1,000 times more potent than caffeine, respectively (95, 97) . Procaine, ruthenium red or Mg2+ inhibits BED or MBED-induced Ca2+ release. The bell-shaped profile of Ca2+ dependence for each compound is very similar to that of caffeine. These stimulatory effects of BED and MBED on the Ca2+ release from skeletal muscle SR are almost indistin guishable from those of caffeine. These results suggest are needed for activation of Cat+-activated K+ channels (99). However, MBED unlike caffeine failed to induce a contraction of skinned smooth muscle strips even at high concentrations. These data strongly suggest that intra cellular Ca2+ stores available for Ca2+-induced Ca2+ re lease channels in smooth muscles may consist of two functionally distinct types, only one of which is sensitive to MBED. It is of great interest that analogues with a carbazole skeleton and bromine at C-6 inhibit both Ca 2+ and caffeine-induced Ca 2+ release (Fig. 7, Table 2 ) (98). 4,6 Dibromo-3-hydroxycarbazole (DBHC) inhibits 45Ca2+ re lease induced by Ca 2+ from SR (Fig. 7, [A] 4) (100). The inhibitory effects of blockers such as procaine, ruthenium red and Mg2+ on 45Ca2+ release are clearly observed at Ca2+ concentrations from pCa 7 to pCa 5.5, whereas that by DBHC is found over a wide range of Ca 2+ concentra tions.
[3H]Ryanodine binding to HSR is suppressed by ruthenium red, Mg2+ and procaine, but is not affected by DBHC.
[3H]MBED binding to HSR is decreased by DBHC and the drug increases the Kd value without affecting the Bm value, indicating a competitive mode of inhibition. These studies lead to the conclusion that DBHC binds to the caffeine/MBED binding site to block Ca 2+ release from SR (100). DBHC is a novel type of in hibitor for Ca2+ release channels in SR and may provide a useful tool for clarifying the Ca2+-release mechanisms in SR.
[3H]-Radiolabeled MBED with a higher specific activ ity has been successfully synthesized. (109) . A probable explanation of these find ings is that MYTX binds to an important regulatory pro tein of Ca2+ release, which is not the ryanodine receptor. Another possible interpretation of all these observations is that MYTX activates two Ca2+-releasing pathways of the ryanodine receptor and a new class of Ca2+ release channels to increase the Ca2+ permeability of the SR membrane. MYTX will be a useful pharmacological tool for clarifying the molecular mechanism of Ca2+ release from skeletal muscle SR.
Recently, we have found that puff-adder lectin (PAL), a novel lectin venom purified from Bitis arietans (Fig. 6) , causes Ca2+ release (EC50=10 PM) from the heavy frac tion but not from the light fraction of skeletal muscle SR (110, 111) . The potency of PAL is approximately 200-fold higher than that of caffeine. The bell-shaped profile of Ca2+ dependence for PAL is almost the same as that for MYTX, but is different from that for caffeine. Typical blockers of Ca2+ release channels including Mg2+ procaine, ruthenium red and ryabodine, markedly in hibits PAL-induced Ca 2+ release from SR. These results suggest that FKBP stabilizes the closed con formation of Ca2+ release channels in skeletal muscle and may thereby play an important role in regulating the kinetics of channel gating during excitation-contraction coupling in skeletal muscle. It has been reported that macrocyclic natural products derived from bromotyrosine isolated from the sponge Ianthella basta selectively modulates the skeletal isoform of the ryanodine-sensitive SR Ca2+ channel by a novel mechanism involving the FKBP/RyR-1 complex (113). Bastadin 5 (Fig. 6) It has been demonstrated that quinolidomicin A1i a 60-membered macrolide from an actinomycete Micromonospora sp (Fig. 6) , markedly induces 45Ca2+ re lease from the heavy fraction of skeletal muscle SR (EC50=20 pM), but induced only slight release from the light fraction of SR, showing a lack of ionphoretic activ ity even at a high concentration (116) . The potency of quinolidomicin Al is 100-fold higher than that of caffeine. The bell-shaped profile of Ca2+ dependence for quinolidomicin Al is different from that for caffeine. Blockers of Ca2+-release channels such as Mgt+, procaine and ruthenium red partially blocked quinolidomicin A1 induced 45Ca2+ release from SR. Quinolidomicin Al potentiates [3H]ryanodine binding to SR with decreasing Kd but without altering Bmax. These results suggest that quinolidomicin A1-induced Ca2+ release from SR consists of two components, one that is sensitive and another that is insensitive to blockers of Ca2+-release channels, and the former component is associated with the ryanodine receptor.
111-2. Natural products that affect Ca2+-pump function
Inhibition of Ca 2+-pump activity by thapsigargin Thapsigargin, a plant-derived sesquiterpenoid lactone (see Fig. 8 ), has been identified as a non-phorboid tumor promoter whose effect appears to result from the em ptying of intracellular Ca2+ stores, as a consequence of inhibiting the uptake pathway. For this reason, thap sigargin has recently attracted the attention of numerous investigators as a tool to define intracellular Ca2+ pools. It has been found that thapsigargin discharges intra cellular Ca 2+ stores in rat hepatocytes (117) . It induces a rapid, concentration-dependent release of stored Ca2+ from liver microsomes. Pretreatment of microsomes with thapsigargin blocks subsequent loading with 45Ca2+, sug gesting that its target is the Ca 2+ pump of the endoplas mic reticulum. Thapsigargin causes an inhibition of the microsomal Ca 2+-ATPase activity without changing the activity of Ca 2+-ATPase on the hepatocyte or erythrocyte plasma membrane. These observations clearly indicate that thapsigargin is a highly specific inhibitor of the endoplasmic reticulum Ca 21 pump (Ca 2+-ATPase) (117) .
Thapsigargin increases [Ca 2+]; in many cell types, probably as a result of Ca2+ release from an intracellular pool (117 119) . In cardiac cells, however, both the contraction and [Ca 2+]; transient have been shown to be inhibited by thapsigargin (119) . Oxalate-stimulated Ca 21 uptake into SR is largely decreased by thapsigargin, whereas Ca2+-induced Ca2+ release is not affected by it.
Furthermore, it has been demonstrated that the sarco lemmal current or transport system is not affected by thapsigargin. Detailed experimental data on the effect of thapsigargin on Ca 2+ movements suggest that thapsigar gin inhibits the contractile response of cardiac muscle by inhibition of SR Ca 2+-ATPase. Thapsigargin has become a valuable probe for clarifying the control of intracellular Ca2+ pools as well as for structure-function studies of the Ca 2+-ATPase molecule itself. Activation of Ca2+-pump activity by gingerol The Ca 2+-ATPase of SR is intimately involved in regulation of the contractile activity of muscles, and the Ca 2+ uptake into SR by Ca 2+-ATPase causes relaxation of muscle fibers. In research aimed at finding cardiotonic substances having unique mechanisms of action from crude drugs, [8] -gingerol (gingerol) was isolated as a cardiotonic principle from the rhisome of ginger, Zin giber officinale Roscoe (Fig. 8) (120) . Gingerol has been demonstrated to induce a positive inotropic effect on iso lated guinea pig left atria (121) . The inotropic effect of gingerol is abolished by ryanodine, but is little affected by propranolol, chlorpheniramine, cimetidine, TTX, diltia zem or reserpine. In the atria, gingerol increases the con tractile force without changing the action potential. Gin gerol increases the Ca2+ uptake of fragmented cardiac SR and the Ca 2+-ATPase activity of cardiac SR at concen trations similar to those that produce cardiotonic action. These results provide the first evidence that the direct en hancement of the Cat+-pumping activity of SR plays an important role in the cardiotonic action of gingerol in atrial muscle.
Gingerol increases the SR Ca2+-pumping rate of not only cardiac SR, but also skeletal SR. The rate of 45Ca2+ uptake of the heavy fraction of SR is also stimulated markedly by gingerol without affecting the 45Ca2+ efflux from the light fraction of SR. Furthermore, gingerol ele vates Ca 2+-ATPase activities of skeletal or cardiac SR. Kinetic analysis of the activating effects of gingerol suggests that the activation of SR Ca 2+-ATPase is both uncompetitive and competitive with respect to Mgt+ ATPase (122) . Kinetic analysis also suggests that the activation by gingerol is of the mixed type with respect to free Ca2+, and this enzyme is activated probably due to the acceleration of enzyme-substrate complex break down. Gingerol may provide an essential chemical tool for investigating the regulatory mechanisms of SR Ca2+ pumping systems and the causal relationship between the Ca2+-pumping activity of SR and muscle contractility.
111-3. Natural products that affect myosin function
Myosin is an ATPase whose activity is stimulated by interaction with actin. There is much evidence suggesting that the conformational changes of actin and myosin are tightly linked to cross-bridge cycling. Although the bind ing sites involved in the interaction between myosin and actin molecules have been determined, the role of these conformational changes and the interactions in muscle contraction remain to be elucidated. Therefore, novel tools that provide information on conformational changes and interactions of contractile proteins will be useful.
Modulation of myosin ATPase activity by purealin
Purealin has been isolated as an ATPase modulater from an Okinawan sea sponge, psammaplysilla purea (see Fig. 9 ). It has been reported that purealin enhances the superprecipitation of skeletal muscle actomyosin (123) and the actin-activated ATPase activity of myosin from rabbit skeletal or cardiac muscle (124, 125) . Of particular interest is the activation of myosin K+ (EDTA)-ATPase by purealin, since no other drug is known to activate K+ (EDTA)-ATPase. Furthermore, similar results concern ing the modification of ATPase activities by purealin were obtained with myosin subfragment-I instead of myosin. These results suggest that purealin enhances the super precipitation of myosin B by affecting the myosin heads directly. This is the first evidence that there is a correla tion between the activities of myosin K+ (EDTA)-ATPase and actomyosin ATPase of myosin B. In contrast, in smooth muscle, the Ca t+ and Mgt+ ATPase activities of dephosphorylated myosin are ele vated by purealin, whereas that of K+ (EDTA)-ATPase is decreased by it (126, 127) . Purealin lessens the ATP-in duced decrease in light scattering of dephosphorylated myosin. Thick filaments of dephosphorylated myosin are preserved by purealin even after administration of ATP.
These findings clearly indicate that purealin modulates the ATPase activity of dephosphorylated smooth muscle myosin by increasing the stability of myosin filaments against the disassembling effect of ATP.
Modification of specific sulfhydryl (SH) groups of myosin by xestoquinone
In the course of our survey of cardiotonic substances having a novel mechanism of action from marine sources, xestoquinone (XQN) has been isolated as a cardiotonic principle from an Okinawan sea sponge, Xestospongia sapra ( Fig. 9) (128) . XQN causes cardiotonic effects on guinea pig left and right atria (129) . An important obser vation is the direct action of XQN on the contractile machinery of cardiac myofilaments in chemically skinned fiber preparations from papillary muscles. The concen tration-contractile response curve for Ca2+ in the atria is substantially shifted to the left by XQN, and this effect is reversed by verapamil. In whole-cell patch-clamped atrial myocytes, XQN increases the slow inward current. cAMP phosphodiesterase activity is inhibited and tissue cAMP content is increased by XQN, suggesting that the elevated cAMP levels may be responsible for the Ca2+ channel ac tivation by XQN. Increases in cAMP content, however, do not occur in parallel with increases in contractile response. These observations suggest that enhancement of intracellular cAMP content and Ca2+ influx across the cell membrane contribute to the late phase of XQN caused cardiotonic responses, whereas the early phase may largely be elicited through direct activation of con tractile elements. XQN may provide a novel lead com pound for developing cardiotonic agents.
Also important is the finding that XQN enhances Ca2+-induced tension development of chemically skinned fibers from guinea pig cardiac muscle, even at free Ca2+ concentrations as low as pCa 9 to 8 (130) . XQN markedly enhances the rate and extent of superprecipitation of natural actomyosin and produces a concentration-depend ent increase in the myofibrillar ATPase activity of ca nine cardiac muscle. These findings clearly indicate that XQN directly activates the actomyosin ATPase activity of cardiac and skeletal myofibrils, thus producing an en hanced superprecipitation activity as well as an increase in skinned fiber contractility.
XQN has been reported to decrease the activities of both Ca 2+ and K+ (EDTA)-ATPase of skeletal muscle myosin. This inhibition is abolished by dithiothreitol, suggesting modification of myosin SH groups by XQN. Recent work in our laboratory showed that unlike N ethylmaleimide, a well-known SH reagent, modification of 2 mol of SH groups per myosin by XQN causes a marked increase in the actomyosin ATPase activity (131) . It is noteworthy that N-ethylmaleimide is still able to modify both the SH1 and SH2 groups after modification of 2 mol of SH groups by XQN. XQN modifies myosin SH groups, which causes changes in the tryptophan fluorescence intensity and circular dichroism. These results suggest that XQN strengthens the interaction be tween actin and myosin through inducing a conforma tional change in the myosin molecule. These observations raises the possibility that XQN modifies specific SH groups in myosin distinct from SH1 and SH2, resulting in activation of actomyosin ATPase. Being a novel positive inotropic agent, XQN should be a valuable chemical tool for studies aimed at elucidating the molecular mecha nisms of muscle contraction.
111-4. Natural products that affect actin function
Actin is one of the most abundant and common com ponents of the cytoskeleton. It also regulates various cell functions such as muscle contraction, cell motility and cell division. It is well-known that cytochalasins, a group of fungal metabolites, serve as actin filaments and shift the polymerization-depolymerization equilibrium toward net depolymerization of F-actin.
Investigation of the relationship between structure and function of actin by goniodomin A Goniodomin A, isolated from the dinoflagellate Goniodoma pseudogoniaulax (see Fig. 9 ) (132) , has been demonstrated to modulate skeletal actomyosin ATPase activity (133) . The effect of goniodomin A is dependent on the concentration of actin, but not that of myosin. The actomyosin ATPase activity is increased by pretreat ment of actin (but not myosin) with goniodomin A. This toxin causes a sustained increase in the fluorescence intensity of actin. However, the ATPase activity and fluorescence intensity of myosin are not changed by goniodomin A. It is of great interest that goniodomin A induces a remarkable but transient increase in the fluorescence intensity of actomyosin in a concentration dependent manner at concentrations similar to those that stimulate the actomyosin ATPase activity. These data suggest that activation of actomyosin ATPase activity by goniodomin A results from the conformational changes of actin molecules. Goniodomin A remarkably decreases the fluorescence intensity of pyrenyl-F-actin to the level of G-actin. Furthermore, electron microscopic observations have clearly demonstrated that actin filaments associate with each other to form a gel in the presence of gonio domin A. These findings suggest that the conformational change of actin molecules, resulting from stoichiometric binding of goniodomin A to actin monomers in filaments, may modify the interaction between actin and myosin. Goniodomin A should become a useful tool for the in vestigation of the relationship between the structure and function of actin.
Depolymerization of actin by mycalolide B Mycalolide B was isolated from the marine sponge Mycale sp. as an antifungal or cytotoxic substance and contains trioxazole in a macrolide ring (Fig. 9) (134) . The toxin inhibits the ATPase of native actomyosin prepared from chicken gizzard smooth muscle without affecting myosin ATPase activities, suggesting that mycalolide B acts directly on either actin or myosin (135) . Mycalolide B does not accelerate actin polymerization, but slowly depolymerizes F-actin (136) . Detailed kinetic analysis has indicated that mycalolide B severs F-actin and forms a 1 : 1 complex with G-actin. The strongest evidence for depolymerization of actin filament by mycalolide B comes from the viscometric and electron microscopic ob servations. These results suggest that mycalolide B severs F-actin and sequesters G-actin to inhibit actin-activated myosin Mgt+-ATPase activity. Mycalolide B is a "depolymerizing" agent , and it has become an important tool for elucidating actin-mediated cellular functions. Fig. 10 .
The chemical structures of natural products that inhibit protein kinases.
IV. Physiological Role of Protein Phosphorylation and Dephosphorylation IV-1. Natural products that affect protein kinase activity
The fungally derived indole carbazoles (staurosporine, K252a and modified derivatives), which interact at the ATP-binding site of protein kinases, have been used ex tensively as inhibitors of serine/threonine (Ser/Thr) kinases (137) . The effects of staurosporine (Fig. 10) have been frequently cited as evidence of protein kinase C (PKC) involvement in a cellular response. Aromatic com pounds such as erbstatin, herbimycin and lavendustin have been isolated from Streptomyces as inhibitors of protein tyrosine kinases. Genistein (Fig. 10) , an isoflavi noid purified from Pseudomonas, inhibits some tyrosine kinases, including those that regulate T-cell proliferation (138) .
It has been reported that certain bioactive, amphipathic polypeptides such as bee venom melittin, antimicrobial antibiotic polymyxin B (Fig. 10) , snake venom cardio toxin, and human neutrophil antibiotic defensin potently inhibit PKC (139) . It is worthy of our notice that these when PKC is activated instead by synaptosomal mem brane. Kinetic analyses indicate that mastoparan inhibits PKC, assayed using phosphatidylserine or synaptosomal membrane as the phospholipid cofactor, competitively with respect to the phospholipid cofactor, in a mixed manner with respect to CaC12 or diacylglycerol, noncom petitively with histone, and uncompetitively with respect to ATP.
IV-2. Natural products that affect phosphatase activity
It is well-known that there are two functional classes of natural inhibitors of phosphatase.
First, there are `endogenous' peptide inhibitors that regulate particular phosphatases within eukaryotic cells; for example, inhibi tors 1 and 2, which are specific for protein phosphatase 1. The second group are secondary metabolites produced by bacteria, fungi, plants, dinoflagellates and insects. The type 1 and 2A protein Ser/Thr phosphatases (PP1 and PP2A) are inhibited by okadaic acid (diarrhetic shellfish poisons from the marine sponge Halichondria okadai and the dinoflagellate Dinophysis forth), tautomycin (anti biotic polyketide from Streptomyces spiroverticillatus), mycrocystin (hepatotoxic cyclic peptide from the blue green algae Mycrocystis aeruginosa) and calyculin A (cytotoxic polyketide from the marine sponge Halichon dria okadai) (Fig. 11) (140) . These inhibitors have been reported to promote tumor formation, suppress cell transformation and induce apoptosis, suggesting that PPl and /or PP2A are components of both growth-stimulat ing and growth-suppressing pathways in cells (141) . Inhi bitors of PP I and PP2A have been widely used as first choice reagents for finding out whether a particular cellu lar process is regulated by reversible protein (Ser/Thr) phosphorylation.
Cyclosporin A is a cyclic undecapeptide of the prokaryote Tolypocladium inflatums (Fig. 11 ). This pep tide has been clinically used as an immunosuppressing drug for organ transplant patients. On entering eukaryotic cells, cyclosporin A binds to a protein called cyclophilin. Another immunosuppressing compound, FK506 (see Fig.  6 ), binds to a distinct protein, FKBP. Both of these drug-protein complexes (cyclosporin-cyclophilin and FK506-FKBP) bind specifically to the Ca2t-activated protein phosphatase 2B (PP2B, calcineurin) to decrease its enzymatic activity (142) . Inhibition of PP2B prevents induction of interleukin 2 (IL-2) expression and hence T cell activation. These drugs are useful as tools for defining the role of PP2B in intracellular signalling. 
